HBG2 and pulmonary arterial hypertension: After ENG treatment, methemoglobin in the PAH+NO group remained at a normal level and did not significantly increase when compared with that in the PAH group (P>0.05) (Fig. 5D), indicating that the therapeutic concentration of NO produced by the ENG did not cause methemoglobinemia.